Case report of three patients with end-stage recurrent glioblastoma treated with meldonium
Abstract Background Glioblastoma is the most aggressive primary brain tumor in adults. The prognosis is still very poor with a median survival time less than a year. A growing body of data supports the role for fatty acid oxidation (FAO) in the aggressive behavior of glioblastoma. We have previously...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | BJC Reports |
| Online Access: | https://doi.org/10.1038/s44276-025-00124-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|